首页> 外文期刊>Laboratory news >Living the single life
【24h】

Living the single life

机译:生活在一起

获取原文
获取原文并翻译 | 示例
           

摘要

Understanding how single cells within an individual person,tissue or organ differ throughout development or as a result of disease has great potential to help advance personalised medicine.Since high throughput single cell applications based on microfluidic droplet technology came to the fore in 2015,researchers have taken advantage of single cell RNA-seq(scRNA-seq)methods to increase their knowledge of cell development,immunology and immunotherapy,as well as tumour heterogeneity,lineage analysis and clonal evolution.The commercial availability of easy-to-use microfluidic instruments has helped drive the acceptance and widespread use of high throughput scRNA-seq,particularly in the materials science and chemistry sectors.Biologists were slower to embrace this technology,perhaps believing that it was necessary to become an expert in setting up microfluidic experiments.Everything changed with the advent of intuitive,application-orientated microfluidic instruments,enabling researchers to explore cell diversity and tissue heterogeneity,and quantify gene expression at the single cell level.
机译:了解各个人,组织或器官内的单个细胞在整个开发过程中的不同或由于疾病有可能帮助推进个性化的药物。基于微流体液滴技术的高通量单细胞应用达到2015年,研究人员在2015年之前出现了利用单细胞RNA-SEQ(SCRNA-SEQ)方法来增加他们对细胞发育,免疫学和免疫疗法的知识,以及肿瘤异质性,谱系分析和克隆演化。易于使用的微流体仪器的商业可用性具有帮助推动了高吞吐量Scrna-SEQ的接受和广泛使用,特别是在材料科学和化学部门。生物学家们越来越慢地拥抱这项技术,也许相信有必要成为建立微流体实验的专家。一切都改变了直观,可应用的微流体仪器的出现,使研究人员能够实现探讨细胞分集和组织异质性,并在单细胞水平上量化基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号